Trials / Completed
CompletedNCT01076309
Corneal Endothelium Cell Loss After Cataract Extraction in Patients Taking Tamsulosin
Corneal Endothelium Cell Loss After Cataract Extraction in Patients Taking Systemic Sympathetic Alfa-1-a-antagonist Medication (Tamsulosin)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (actual)
- Sponsor
- Frederiksberg University Hospital · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether corneal endothelium cell loss during cataract surgery is higher in patients taking Tamsulosin.
Detailed description
Cataract surgery in patients taking Tamsulosin is regarded as more challenging for the surgeon because Intraoperative Floppy Iris Syndrome (IFIS) might occur. However, the question is whether this has any practical implication for the outcomes of surgery. In this study we investigate whether cornea is damage during surgery on Tamsulosin patient. In an observational study 30 cataract patients taking Tamsulosin is compared to 30 patients not taking Tamsulosin, but otherwise similar. Number of patients is based on power calculation. Cornea is examined by specular microscopy.
Conditions
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-09-01
- Completion
- 2010-09-01
- First posted
- 2010-02-26
- Last updated
- 2011-07-21
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT01076309. Inclusion in this directory is not an endorsement.